VERAXA Biotech AG

Healthcare · Biotechnology · Germany

Last price 1.16 USD (Oct 30, 2026, 2:22 PM EDT) · Market cap 164.03M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Veraxa Biotech AG develops antibody-based therapeutics and antibody-drug conjugates for cancer treatment. The company develops antibody-based therapeutics, including antibody-drug conjugates and bispecific antibody formats, and offers a proprietary technology platform for functional antibody screening and bioconjugation. Its product pipeline includes drug candidates such as ADCs and BITACs, with some in clinical development, and it provides partnership models for collaborative development from target identification to antibody and ADC creation....